2(S)-[2-氧代-4(R)-丙基吡咯烷-1-基]丁酰胺

2(S)-[2-氧代-4(R)-丙基吡咯烷-1-基]丁酰胺（CAS 357336-20-0）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的理化数值

在册的记载用途

Used as adjunctive therapy for partial-onset seizures in patients 16 years of age or older.Brivaracetam is a relatively unique anticonvulsant that is typically used in combination with other antiepileptic medications for partial onset seizures. Brivaracetam has been linked to rare instances of serum aminotransferase and alkaline phosphatase elevations during treatment and is suspected of causing rare cases of clinically apparent drug induced liver disease.

同义词与商品名

Brivaracetam; 357336-20-0; Briviact; UCB 34714; UCB-34714; UCB34714; (2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-yl]butanamide; U863JGG2IA; 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-4-propyl-, (alphaS,4R)-; CHEBI:133013; DTXSID00905081; (2S)-2-((4R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide; brivaracetamum; RefChem:57048; N03AX23; DTXCID601334183

GHS 危害分类

Reported hazard statements	H302 (66.7%), H336 (33.3%)

H302 (66.7%): Harmful if swallowed [Warning Acute toxicity, oral]

H336 (33.3%): May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposure; Narcotic effects]

公开数据库对它的描述

2(S)-[2-Oxo-4(R)-propylpyrrolidin-1-yl]butyramide · CAS 357336-20-0 · C11H20N2O2. UNII U863JGG2IA. European Pharmacopoeia monograph. LogP: 1.0.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。